Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed with Simplified vs Standard Supplementation in NSCLC
NCT00609518Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of pemetrexed in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Eli Lilly and Company. Started Feb 2008; status: completed.
02
Drugs
pemetrexed
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT00609518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609518.